vs
Side-by-side financial comparison of Royalty Pharma plc (RPRX) and VALMONT INDUSTRIES INC (VMI). Click either name above to swap in a different company.
VALMONT INDUSTRIES INC is the larger business by last-quarter revenue ($1.0B vs $622.0M, roughly 1.7× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 16.2%, a 18.3% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs 0.1%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs 3.0%).
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
Valmont Industries, Inc. is a large, publicly held American manufacturer of Valley center pivot and linear irrigation equipment, windmill support structures, lighting and traffic poles and steel utility poles.
RPRX vs VMI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $622.0M | $1.0B |
| Net Profit | $214.2M | $168.0M |
| Gross Margin | — | 29.8% |
| Operating Margin | 62.4% | 11.2% |
| Net Margin | 34.4% | 16.2% |
| Revenue YoY | 4.8% | 0.1% |
| Net Profit YoY | 2.9% | 116.3% |
| EPS (diluted) | $0.49 | $9.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $622.0M | $1.0B | ||
| Q3 25 | $609.3M | $1.0B | ||
| Q2 25 | $578.7M | $1.1B | ||
| Q1 25 | $568.2M | $969.3M | ||
| Q4 24 | $593.6M | $1.0B | ||
| Q3 24 | $564.7M | $1.0B | ||
| Q2 24 | $537.3M | $1.0B | ||
| Q1 24 | $568.0M | $977.8M |
| Q4 25 | $214.2M | $168.0M | ||
| Q3 25 | $288.2M | $99.0M | ||
| Q2 25 | $30.2M | $-4.0M | ||
| Q1 25 | $238.3M | $87.3M | ||
| Q4 24 | $208.2M | $77.7M | ||
| Q3 24 | $544.0M | $83.1M | ||
| Q2 24 | $102.0M | $99.7M | ||
| Q1 24 | $4.8M | $87.8M |
| Q4 25 | — | 29.8% | ||
| Q3 25 | — | 30.4% | ||
| Q2 25 | — | 30.6% | ||
| Q1 25 | — | 30.0% | ||
| Q4 24 | — | 30.2% | ||
| Q3 24 | — | 29.6% | ||
| Q2 24 | — | 30.8% | ||
| Q1 24 | — | 31.3% |
| Q4 25 | 62.4% | 11.2% | ||
| Q3 25 | 70.1% | 13.5% | ||
| Q2 25 | 36.3% | 2.8% | ||
| Q1 25 | 94.0% | 13.2% | ||
| Q4 24 | 60.9% | 11.6% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | 50.2% | 14.2% | ||
| Q1 24 | -13.0% | 13.5% |
| Q4 25 | 34.4% | 16.2% | ||
| Q3 25 | 47.3% | 9.5% | ||
| Q2 25 | 5.2% | -0.4% | ||
| Q1 25 | 41.9% | 9.0% | ||
| Q4 24 | 35.1% | 7.5% | ||
| Q3 24 | 96.3% | 8.1% | ||
| Q2 24 | 19.0% | 9.6% | ||
| Q1 24 | 0.8% | 9.0% |
| Q4 25 | $0.49 | $9.02 | ||
| Q3 25 | $0.67 | $4.98 | ||
| Q2 25 | $0.07 | $-1.53 | ||
| Q1 25 | $0.55 | $4.32 | ||
| Q4 24 | $0.46 | $3.85 | ||
| Q3 24 | $1.21 | $4.11 | ||
| Q2 24 | $0.23 | $4.91 | ||
| Q1 24 | $0.01 | $4.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $618.7M | $187.1M |
| Total DebtLower is stronger | $9.0B | $795.7M |
| Stockholders' EquityBook value | $9.7B | $1.6B |
| Total Assets | $19.6B | $3.4B |
| Debt / EquityLower = less leverage | 0.92× | 0.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $618.7M | $187.1M | ||
| Q3 25 | $938.9M | $226.1M | ||
| Q2 25 | $631.9M | $208.5M | ||
| Q1 25 | $1.1B | $184.4M | ||
| Q4 24 | $929.0M | $164.3M | ||
| Q3 24 | $950.1M | $200.5M | ||
| Q2 24 | $1.8B | $163.1M | ||
| Q1 24 | $843.0M | $169.2M |
| Q4 25 | $9.0B | $795.7M | ||
| Q3 25 | $8.9B | — | ||
| Q2 25 | $8.0B | — | ||
| Q1 25 | $7.6B | — | ||
| Q4 24 | $7.6B | $730.6M | ||
| Q3 24 | $7.6B | — | ||
| Q2 24 | $7.6B | — | ||
| Q1 24 | $6.1B | — |
| Q4 25 | $9.7B | $1.6B | ||
| Q3 25 | $9.6B | $1.6B | ||
| Q2 25 | $9.5B | $1.5B | ||
| Q1 25 | $9.8B | $1.6B | ||
| Q4 24 | $10.3B | $1.5B | ||
| Q3 24 | $10.3B | $1.5B | ||
| Q2 24 | $9.8B | $1.5B | ||
| Q1 24 | $9.9B | $1.4B |
| Q4 25 | $19.6B | $3.4B | ||
| Q3 25 | $19.3B | $3.4B | ||
| Q2 25 | $18.3B | $3.3B | ||
| Q1 25 | $17.6B | $3.4B | ||
| Q4 24 | $18.2B | $3.3B | ||
| Q3 24 | $18.0B | $3.5B | ||
| Q2 24 | $17.7B | $3.5B | ||
| Q1 24 | $16.1B | $3.5B |
| Q4 25 | 0.92× | 0.49× | ||
| Q3 25 | 0.93× | — | ||
| Q2 25 | 0.84× | — | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | 0.74× | 0.47× | ||
| Q3 24 | 0.74× | — | ||
| Q2 24 | 0.78× | — | ||
| Q1 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $827.1M | $111.2M |
| Free Cash FlowOCF − Capex | — | $70.4M |
| FCF MarginFCF / Revenue | — | 6.8% |
| Capex IntensityCapex / Revenue | — | 3.9% |
| Cash ConversionOCF / Net Profit | 3.86× | 0.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $311.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $827.1M | $111.2M | ||
| Q3 25 | $702.6M | $112.5M | ||
| Q2 25 | $364.0M | $167.6M | ||
| Q1 25 | $596.1M | $65.1M | ||
| Q4 24 | $742.5M | $193.4M | ||
| Q3 24 | $703.6M | $225.1M | ||
| Q2 24 | $658.2M | $130.8M | ||
| Q1 24 | $664.6M | $23.3M |
| Q4 25 | — | $70.4M | ||
| Q3 25 | — | $70.6M | ||
| Q2 25 | — | $135.6M | ||
| Q1 25 | — | $34.8M | ||
| Q4 24 | — | $167.8M | ||
| Q3 24 | — | $204.6M | ||
| Q2 24 | — | $112.5M | ||
| Q1 24 | — | $8.3M |
| Q4 25 | — | 6.8% | ||
| Q3 25 | — | 6.7% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 3.6% | ||
| Q4 24 | — | 16.2% | ||
| Q3 24 | — | 20.1% | ||
| Q2 24 | — | 10.8% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | — | 3.9% | ||
| Q3 25 | — | 4.0% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 3.1% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 1.8% | ||
| Q1 24 | — | 1.5% |
| Q4 25 | 3.86× | 0.66× | ||
| Q3 25 | 2.44× | 1.14× | ||
| Q2 25 | 12.06× | — | ||
| Q1 25 | 2.50× | 0.75× | ||
| Q4 24 | 3.57× | 2.49× | ||
| Q3 24 | 1.29× | 2.71× | ||
| Q2 24 | 6.45× | 1.31× | ||
| Q1 24 | 139.10× | 0.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
VMI
| Utility Product Line | $424.5M | 41% |
| Lighting And Transportation | $204.6M | 20% |
| Irrigation Equipment And Parts Excluding Technology | $199.0M | 19% |
| Services | $113.6M | 11% |
| Telecommunications | $73.8M | 7% |
| Technology Products And Services | $23.7M | 2% |
